{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:42:38Z","timestamp":1793392958162,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1309600"],"award-info":[{"award-number":["2017YFC1309600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2008085MH248"],"award-info":[{"award-number":["2008085MH248"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Type 1 diabetes (T1D) progression is affected by circulating glutamic acid decarboxylase antibody (GADA) that persist for many years. This study aimed at investigating whether and how the gut microbiome and its correlated metabolites change in T1D with the presence of GADA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used a radiobinding assay to measure GADA titers and identify the 49 T1D patients with GADA+ and 52 T1D patients with GADA-. The fresh feces and serum were analyzed using 16S rRNA gene sequencing and GC\/MS. Then gut microbiome and serum metabolites were compared between the GADA+ patients and the GADA- patients. The association between gut microbial community and metabolites was assessed using the Spearman\u2019s rank correlation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The gut microbiome in diversity, composition, and function differed between these two groups. The abundance of genus <jats:italic>Alistipes<\/jats:italic>, <jats:italic>Ruminococcus<\/jats:italic> significantly increased in patients with GADA+ compared to that observed in the samples of GADA-. There were 54 significantly altered serum metabolites associated with tryptophan metabolism, phenylalanine, and tyrosine biosynthesis in individuals with GADA+ compared with those of GADA-For the serum metabolites, compared with those of GADA-, there were 54 significantly different metabolites with tryptophan metabolism, phenylalanine, and tyrosine and tryptophan biosynthesis decreased in individuals with GADA+. The abundance of <jats:italic>Alistipes<\/jats:italic> was positively correlated with altered metabolites involved in tryptophan metabolism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We demonstrate that T1D patients with GADA+ are characterised by aberrant profiles of gut microbiota and serum metabolites. The abundance of <jats:italic>Alistipes<\/jats:italic> disturbances may participate in the development of T1D patients with GADA by modulating the host\u2019s tryptophan metabolism. These findings extend our insights into the association between the gut microbiota and tryptophan metabolism and GADA and might be targeted for preventing the development of T1D.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.938358","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T12:39:07Z","timestamp":1664541547000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADA"],"prefix":"10.3389","volume":"13","author":[{"given":"Sihui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dbi20-0026","article-title":"Modulation of leukocytes of the innate arm of the immune system as a potential approach to prevent the onset and progression of type 1 diabetes","volume":"70","author":"Petrelli","year":"2021","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0238","article-title":"Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: The TEDDY study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0425","article-title":"The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients","volume":"36","author":"Sosenko","year":"2013","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2337\/dc14-1770","article-title":"Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: A nationwide, multicenter prospective study (LADA China study 3)","volume":"38","author":"Liu","year":"2015","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108847","article-title":"Associated autoimmunity in type 1 diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies","volume":"175","author":"Gougourelas","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2010.00666.x","article-title":"GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis","volume":"12","author":"Kordonouri","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/genes10100748","article-title":"Comparative analysis of fecal microbiota composition between rheumatoid arthritis and osteoarthritis patients","volume":"10","author":"Lee","year":"2019","journal-title":"Genes (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00125","article-title":"Evaluating the causal role of gut microbiota in type 1 diabetes and its possible pathogenic mechanisms","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1038\/s41598-019-46087-x","article-title":"Type 1 diabetes: an association between autoimmunity, the dynamics of gut amyloid-producing e","volume":"9","author":"Tetz","year":"2019","journal-title":"coli Their Phages Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.01.001","article-title":"The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes","volume":"17","author":"Kostic","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","article-title":"A universal gut-Microbiome-Derived signature predicts cirrhosis","volume":"32","author":"Oh","year":"2020","journal-title":"Cell Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05260-y","article-title":"Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria","volume":"63","author":"Winther","year":"2020","journal-title":"Diabetologia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0620-2","article-title":"The human gut microbiome in early-onset type 1 diabetes from the TEDDY study","volume":"562","author":"Vatanen","year":"2018","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.04.032","article-title":"Gut microbiota profiling in han Chinese with type 1 diabetes","volume":"141","author":"Huang","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5295","article-title":"Incidence of type 1 diabetes in China, 2010-13: population based study","volume":"360","author":"Weng","year":"2018","journal-title":"Bmj"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12366","article-title":"Demographic and clinical characteristics of patients with type 1 diabetes mellitus: A multicenter registry study in guangdong, China","volume":"8","author":"Yang","year":"2016","journal-title":"J Diabetes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.21037\/atm-20-7471","article-title":"Residual \u03b2-cell function after 10 years of autoimmune type 1 diabetes: prevalence, possible determinants, and implications for metabolism","volume":"9","author":"Cheng","year":"2021","journal-title":"Ann Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr507","article-title":"FLASH: fast length adjustment of short reads to improve genome assemblies","volume":"27","author":"Mago\u010d","year":"2011","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8728-3_11","article-title":"Predicting the functional potential of the microbiome from marker genes using PICRUSt","volume":"1849","author":"Douglas","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaa188","article-title":"M2IA: a web server for microbiome and metabolome integrative analysis","volume":"36","author":"Ni","year":"2020","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci143683","article-title":"A little help from residual \u03b2 cells has long-lasting clinical benefits","volume":"131","author":"Lam","year":"2021","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0465-3","article-title":"Increased intestinal permeability precedes clinical onset of type 1 diabetes","volume":"49","author":"Bosi","year":"2006","journal-title":"Diabetologia"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-46","article-title":"Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study","volume":"11","author":"Murri","year":"2013","journal-title":"BMC Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0253","article-title":"Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: A case-control study","volume":"41","author":"Leiva-Gea","year":"2018","journal-title":"Diabetes Care"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.182841","article-title":"Imbalance of fecal microbiota at newly diagnosed type 1 diabetes in Chinese children","volume":"129","author":"Qi","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40104-019-0402-1","article-title":"Clostridium species as probiotics: potentials and challenges","volume":"11","author":"Guo","year":"2020","journal-title":"J Anim Sci Biotechnol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.072","article-title":"Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome","volume":"141","author":"Saulnier","year":"2011","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00906","article-title":"The genus alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health","volume":"11","author":"Parker","year":"2020","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B37","doi-asserted-by":"publisher","first-page":"17025","DOI":"10.1038\/s41598-020-74183-w","article-title":"Neopterin and biopterin levels and tryptophan degradation in patients with diabetes","volume":"10","author":"G\u00fcrc\u00fc","year":"2020","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21849","article-title":"Serum analysis of tryptophan catabolism pathway: correlation with crohn's disease activity","volume":"18","author":"Gupta","year":"2012","journal-title":"Inflammation Bowel Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2017.06.007","article-title":"Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation","volume":"22","author":"Wlodarska","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1788899","article-title":"Intestinal microbiota-derived tryptophan metabolites are predictive of ah receptor activity","volume":"12","author":"Dong","year":"2020","journal-title":"Gut Microbes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"248.e231","DOI":"10.1053\/j.gastro.2011.04.007","article-title":"Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract","author":"Monteleone","year":"2011","journal-title":"Gastroenterol 141(1)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.938358\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T12:39:11Z","timestamp":1664541551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.938358\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":42,"alternative-id":["10.3389\/fendo.2022.938358"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.938358","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"article-number":"938358"}}